PROM1 and brain cancer: Considering the potential prognostic importance of CD133/AC133 as identity marker for GSCs and a predictor of the therapeutic response in malignant brain tumours [9], the clarification of controversial findings regarding CD133/AC133 is an issue of the biological and clinical significance.